Zobrazeno 1 - 10
of 34
pro vyhledávání: '"John J Orloff"'
Autor:
John J Orloff, Donald Stanski
Publikováno v:
Annali dell'Istituto Superiore di Sanità, Vol 47, Iss 1, Pp 8-13 (2011)
Pharmaceutical innovation is increasingly risky, costly and at times inefficient, which has led to a decline in industry productivity. Despite the increased investment in R&D by the industry, the number of new molecular entities achieving marketing a
Externí odkaz:
https://doaj.org/article/3094b39fe4894f298f19e7021c600d85
Autor:
Flagship Ventures, Steven E. Weinberger, Steven K. Galson, Samuel R. Nussbaum, Michelle McMurry-Heath, Marc M. Boutin, John J. Orloff, Michael Rosenblatt, Christopher P. Austin, Janet Woodcock, William W. Chin, Sachin H. Jain
Publikováno v:
NAM Perspectives. 6
Publikováno v:
NAM Perspectives. 6
Publikováno v:
Journal of Bone and Mineral Research. 6:279-287
Parathyroid hormone (PTH) and PTH-related proteins (PTHrP) interact with a common receptor in rat bone cells and in canine renal membranes with similar affinity, but PTHrP are substantially less potent than PTH in stimulating adenylate cyclase in can
Autor:
John J. Orloff, Susan K. Ewing, Desmond E. Thompson, Dennis M. Black, Marc C. Hochberg, Pierre D. Delmas, Douglas C. Bauer, Susan M. Ott, P. Garnero
Publikováno v:
Journal of Bone and Mineral Research. 19:1250-1258
We used data from the Fracture Intervention Trial to assess the relationship change in bone turnover after 1 year of alendronate or placebo treatment and subsequent hip, non-spine, and spine fracture risk among 6186 postmenopausal women. In the alend
Autor:
Henry G. Bone, Tobias J. de Villiers, Nigel Gilchrist, Mei X. Wu, Daifotis Anastasia G, John J. Orloff, Arthur C. Santora, Marjorie M Luckey, Michael W Davie
Publikováno v:
Obstetrics & Gynecology. 101:711-721
To evaluate the efficacy and safety of alendronate 35 mg once weekly compared with alendronate 5 mg daily in the prevention of osteoporosis.We compared the efficacy and safety of treatment with alendronate 35 mg once weekly (n = 362) and alendronate
Autor:
Kai Yang, Scott K. Van Why, Lina Golovyan, Andrew F. Stewart, Richard A. Zager, Susan C. Galbraith, Norman J. Siegel, Pamela Dann, John J. Orloff, Adolfo Garcia-Ocaña
Publikováno v:
Journal of the American Society of Nephrology. 10:238-244
Parathyroid hormone (PTH)-related protein (PTHrP) is widely expressed in normal fetal and adult tissues and regulates growth and differentiation in a number of organ systems. Although various renal cell types produce PTHrP, and PTHrP expression in ra
Autor:
James F. McCaughern-Carucci, John J. Wysolmerski, Andrew C. Karaplis, Peter Young, Jian Ping Zhang, Gerald R. Cunha, Maureen E. Dunbar, John J. Orloff, Beate Lanske
Publikováno v:
Developmental Biology. 203(1):75-89
Parathyroid hormone-related protein (PTHrP) was originally identified as the tumor product responsible for humoral hypercalcemia of malignancy. It is now known that PTHrP is produced by many normal tissues in which it appears to play a role as a deve
Autor:
C M Isales, M S Moyer, M Mitnick, A Behal, J Gasalla-Herraiz, Y Kats, John J. Orloff, M H Nathanson, Michael B. Ganz
Publikováno v:
Endocrinology. 137:5376-5385
A midregion fragment of PTH-related protein (PTHrP), which is intensively conserved across species, has been identified as a secretory product of several different cell types, including keratinocytes and squamous carcinomas. As recent data suggest th
Autor:
Yuliya Kats, Gino V. Segre, Ernestina Schipani, Abdul B. Abou-Samra, Pablo Urena, John J. Orloff, Rupangi C. Vasavada, William M. Philbrick, Amita Behal, Harald Jüppner
Publikováno v:
Endocrinology. 136:3016-3023
PTH and PTH-related peptides (PTHrPs) interact with a common PTH/PTHrP receptor (type I), which is expressed in many tissues, including bone and kidney. Amino-terminal PTH and PTHrPs also recognize receptors in several nonclassical PTH target tissues